Chemical Structure : AZD4547
CAS No.: 1035270-39-3
货号: PC-43499Not For Human Use, Lab Use Only.
Fexagratinib (AZD4547, ADSK091) is a potent and selective inhibitor of FGFR1/2/3 with IC50s of 0.2/1.8/2.5 nM, respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥580 | In stock | |
10 mg | ¥880 | In stock | |
50 mg | ¥1980 | In stock | |
100 mg | ¥3280 | In stock | |
250 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Fexagratinib (AZD4547, ADSK091) is a potent and selective inhibitor of FGFR1/2/3 with IC50s of 0.2/1.8/2.5 nM, respectively.
AZD4547 shows weak acticity against KDR(IC50=24 nM), FGFR4 (IC50=165 nM) and IGFR (IC50=581 nM), and on activity against CDK2, Axl, FAK, p38 etc.
AZD4547 suppresses FGFR signaling and growth in tumor cell lines with deregulated FGFR expression.
AZD4547 is orally bioavailable.
分子量 | 463.5719 | |
分子式 | C26H33N5O3 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
Benzamide, N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-, rel- |
1. Gavine PR, et al. Cancer Res. 2012 Apr 15;72(8):2045-56.
2. Zhang J, et al. Clin Cancer Res. 2012 Dec 15;18(24):6658-67.
3. Kwak Y, et al. Mol Cancer Ther. 2015 Oct;14(10):2292-302.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright